- Home
- ZYME vs KOS Comparison
ZYME vs KOS Comparison
Compare ZYME & KOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- KOS
- Stock Information
- Founded
- ZYME 2003
- KOS 2003
- Country
- ZYME United States
- KOS United States
- Employees
- ZYME N/A
- KOS N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- KOS Oil & Gas Production
- Sector
- ZYME Health Care
- KOS Energy
- Exchange
- ZYME Nasdaq
- KOS Nasdaq
- Market Cap
- ZYME 846.1M
- KOS 817.4M
- IPO Year
- ZYME 2017
- KOS 2011
- Fundamental
- Price
- ZYME $11.31
- KOS $1.80
- Analyst Decision
- ZYME Buy
- KOS Strong Buy
- Analyst Count
- ZYME 6
- KOS 6
- Target Price
- ZYME $19.50
- KOS $5.18
- AVG Volume (30 Days)
- ZYME 553.2K
- KOS 10.8M
- Earning Date
- ZYME 05-08-2025
- KOS 05-06-2025
- Dividend Yield
- ZYME N/A
- KOS N/A
- EPS Growth
- ZYME N/A
- KOS N/A
- EPS
- ZYME N/A
- KOS N/A
- Revenue
- ZYME $93,384,000.00
- KOS $1,546,854,000.00
- Revenue This Year
- ZYME $26.29
- KOS $1.22
- Revenue Next Year
- ZYME $75.78
- KOS $9.43
- P/E Ratio
- ZYME N/A
- KOS N/A
- Revenue Growth
- ZYME 85.05
- KOS N/A
- 52 Week Low
- ZYME $8.21
- KOS $1.39
- 52 Week High
- ZYME $17.70
- KOS $6.33
- Technical
- Relative Strength Index (RSI)
- ZYME 40.96
- KOS 50.53
- Support Level
- ZYME $10.86
- KOS $1.50
- Resistance Level
- ZYME $13.23
- KOS $1.72
- Average True Range (ATR)
- ZYME 0.56
- KOS 0.12
- MACD
- ZYME -0.10
- KOS 0.03
- Stochastic Oscillator
- ZYME 18.78
- KOS 78.41
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About KOS Kosmos Energy Ltd. (DE)
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.